Skip to content

Clinical trials

Withdrawn Fallopian Tube Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Status: Withdrawn Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20081
20101
20112
20123
20131
20151
20164
20171
20183
20214
20221
20233
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group5
Roswell Park Cancer Institute3
Dana-Farber Cancer Institute2
M.D. Anderson Cancer Center2
AGO Research GmbH1
Barbara Ann Karmanos Cancer Institute1
Bio-Thera Solutions1
City of Hope Medical Center1
Eastern Cooperative Oncology Group1
Emory University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms34
Ovarian Neoplasms25
Carcinoma, Ovarian Epithelial10
Breast Neoplasms4
Uterine Cervical Neoplasms4
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Neoplasm Metastasis2
Triple Negative Breast Neoplasms2
Brenner Tumor1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.